No,구분,개별,평가의뢰일,평가의뢰기관,재평가,평가의뢰종목,법인번호,평가종류,회차,민감도,주기,기준일,평가값송부일,보고서송부일,민감도송부일,평가담당자,공수,전기평가,RM,결과보고서송부,등록월,등록그룹,담당자,연락처,Mail,평가목적,종목등록일
586,-,개별종목,2024-08-26,삼성생명(수익증권),재평가,하나발전인프라제1호사모투자전문회사,1101130018548 ,B01,0,-,분기 ,2024-09-30,평가철회,평가철회,-,김예림, 1.0 ,김예림,김기욱,김기욱,평가철회,평가철회,"김민규프로,이승엽프로,신민영프로",02-2074-2182,mk0710.kim@samsung.com;simba90.lee@samsung.com;my74.shin@samsung.com,-,0
1587,본평가 : 2024-10-10,개별종목,2024-08-27,"아이엠라이프(구,DGB생명보험)(수익증권)",재평가,GOLUB CAPITAL PARTNERS INTERNATIONAL 11,KBP2022030073,B02,0,-,분기 ,2024-09-30,평가철회,평가철회,-,대체평가3사업본부, - ,대체평가3사업본부,유수연,유수연,평가철회,평가철회,박지애과장 , ,parkjiae@dgbfn.com ,-,0
2014,전량매각,기초자산,교보생명보험펀드(기초자산),에스비아이아세안스프링보드투자조합,재평가,화동인터네셔널그룹,KBP2019060021,A07,0,-,분기,2024-09-30,평가철회,평가철회,-,정재형, - ,정재형,-,-,평가철회,평가철회,0,0,0,-,0
2786,"1차가격 : 2024-10-07, 2차가격 : 2024-10-10, 최종가격 : 2024-10-14",개별종목,2024-08-30,롯데손해보험,재평가,미래에셋THAMESLINK전문투자형사모특별자산투자신탁1호,KBP2019090124,B02,0,-,분기 ,2024-09-30,평가철회,평가철회,-,대체평가3사업본부, - ,대체평가3사업본부,정창수,정창수,평가철회,평가철회,정현진수석,hyunjin.chung@lotteins.co.kr,410000287,-,0
4185,전량 보통주 전환,기초자산,키움증권펀드(기초자산),라이프밸류업사모투자,재평가,동국생명과학,1101116391778 ,A07,0,-,분기 ,2024-09-30,평가철회,평가철회,-,심태진, - ,심태진,-,-,평가철회,평가철회,0,0,0,-,0
5281,"최종결과송부 : 2024-10-04, 세부편입자산리스트 : 2024-10-17",개별종목,2024-09-23,DB손해보험(수익증권),재평가,CRS Evergreen,KBP2024060044,B02,0,-,분기 ,2024-09-30,2024-09-20,2024-10-17,-,대체평가3사업본부, - ,대체평가3사업본부,서동현/조용원,서동현/조용원,202409,[T]기타보험기관[1본부],박희만 ,02-331-5462 ,parkheeman@dbins.co.kr ,-,0
5282,-,개별종목,2024-09-23,대동,재평가,대동,1911110000104 ,A05,1,-,분기 ,2024-09-30,2024-10-17,2024-10-25,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202409,[W]상장기업,조국봉대리,02-3470-7409,cgb8733@daedong.co.kr,회계반영,0
5283,-,개별종목,2024-09-23,대동,재평가,대동,1911110000104 ,A05,2,-,분기 ,2024-09-30,2024-10-17,2024-10-25,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202409,[W]상장기업,조국봉대리,02-3470-7409,cgb8733@daedong.co.kr,회계반영,0
5284,-,개별종목,2024-09-23,SK텔레콤,재평가,SK텔레콤,1101110371346 ,D06,0,-,분기 ,2024-09-30,2024-10-07,2024-10-14,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202409,[W]상장기업,조예인매니저,010-8269-1515,y27.cho@sk.com,회계반영,0
5285,-,개별종목,2024-09-23,SK텔레콤,재평가,SK텔레콤,1101110371346 ,D06,1,-,분기 ,2024-09-30,2024-10-07,2024-10-14,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202409,[W]상장기업,조예인매니저,010-8269-1515,y27.cho@sk.com,회계반영,0
5286,-,개별종목,2024-09-23,SK텔레콤,재평가,SK텔레콤,1101110371346 ,D06,2,-,분기 ,2024-09-30,2024-10-07,2024-10-14,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202409,[W]상장기업,조예인매니저,010-8269-1515,y27.cho@sk.com,회계반영,0
5287,-,개별종목,2024-09-23,SK텔레콤,재평가,SK텔레콤,1101110371346 ,D06,3,-,분기 ,2024-09-30,2024-10-07,2024-10-14,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202409,[W]상장기업,조예인매니저,010-8269-1515,y27.cho@sk.com,회계반영,0
5288,-,개별종목,2024-09-23,SK텔레콤,재평가,SK텔레콤,1101110371346 ,D06,4,-,분기 ,2024-09-30,2024-10-07,2024-10-14,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202409,[W]상장기업,조예인매니저,010-8269-1515,y27.cho@sk.com,회계반영,0
5289,교보와이지일구이무신기술투자조합,개별종목,2024-09-23,교보와이지일구이무신기술투자조합,재평가,"원바이오젠(구,교보8호기업인수목적)",1101116860442 ,D02,2,-,분기,2024-09-30,2024-10-04,2024-10-11,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202409,[W]상장기업,강민지대리,02-3140-4673,kmz@ygmail.net,-,0
5290,-,기초자산,교보생명보험펀드(기초자산),KTBN18호벤처투자조합,신규,"휴럼(구,엔에이치기업인수목적16호)",1101117442710 ,D02,77,-,분기,2024-09-30,2024-09-13,보고서제공X,-,상장, - ,상장,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
5291,-,기초자산,교보생명보험펀드(기초자산),KTBN18호벤처투자조합,신규,아이겐코리아,1101118994835 ,A05,77,-,분기,2024-09-30,2024-09-13,보고서제공X,-,오영석, - ,신규,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
5292,-,기초자산,교보생명보험펀드(기초자산),KTBN18호벤처투자조합,신규,메디웨일,1101116275485 ,A07,77,-,분기,2024-09-30,2024-09-13,보고서제공X,-,김예림, - ,김예림,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
5293,-,개별종목,2024-09-23,인산가,재평가,인산가,1101116471554 ,D02,9,-,분기,2024-09-30,2024-10-11,2024-10-21,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202409,[W]상장기업,이정선차장 ,02-767-2081 ,ljs525@insanga.co.kr;seunghwan091@insanga.co.kr,회계반영,0
5294,-,개별종목,2024-09-23,인산가,신규,인산가,1101116471554 ,D02,10,-,분기,2024-09-30,2024-10-11,2024-10-21,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202409,[W]상장기업,이정선차장 ,02-767-2081 ,ljs525@insanga.co.kr;seunghwan091@insanga.co.kr,회계반영,0
5295,-,기초자산,"IBK투자증권(PI부)(구,투자금융팀)펀드(기초자산)",레이크브릿지제8호사모투자,신규,제이오,1244110019788 ,D01,77,-,분기,2024-09-30,2024-10-08,보고서제공X,-,상장, - ,상장,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
5296,-,기초자산,시냅틱인베스트먼트펀드(기초자산),시냅틱미래성장제1호사모투자,신규,씨에스윈드,1101113509887 ,D01,77,-,분기,2024-09-30,2024-10-08,보고서제공X,-,상장, - ,상장,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
5297,-,개별종목,2024-09-23,인콘,재평가,"빌리언스(구,블레이드엔터테인먼트)",1501110000765 ,D02,5,-,분기 ,2024-09-30,2024-10-08,2024-10-15,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202409,[W]상장기업,윤영호주임,070-5075-0207,rbfldbs@incon.kr,회계반영,0
5298,-,개별종목,2024-09-23,인콘,재평가,판타지오,1601110023757 ,D02,7,-,분기 ,2024-09-30,2024-10-08,2024-10-15,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202409,[W]상장기업,윤영호주임,070-5075-0207,rbfldbs@incon.kr,회계반영,0
